Nexus Surgical and Medicare Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 105611, "name": "Nexus Surgical", "stock_name": "Nexus Surgical", "full_name": "Nexus Surgical and Medicare Ltd", "name_url": "stocks-analysis/nexus-surgical", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "20.40", "chg": -0.09, "chgp": "-0.44%", "dir": -1, "prev_price": "20.49", "mcapval": "11.00 Cr", "mcap": "Micro Cap", "scripcode": 538874, "symbol": "", "ind_name": "Non Banking Financial Company (NBFC)", "ind_code": 5, "sector_id": 51, "indexname": "India SENSEX", "isin": "INE370Q01015", "curr_date": "Jun 03, 03:30 PM", "curr_time": "04:43 AM", "last_traded_at": "Jun 03, 03:30 PM IST", "bse_nse_vol": "130 ", "exc_status": "Active", "traded_date": "Jun 03, 2026", "traded_date_str": "2026 06 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nexus-surgical-105611-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Nexus Surgical Falls 13.44%: Key Financial Trends Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-falls-1344-key-financial-trends-amid-market-volatility-4024753", "imagepath": "", "date": "2026-05-31 17:02:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 25:</strong> Stock plunges 8.61% to Rs.21.01 amid broad market rally</p>\n <p><strong>May 26:</strong> Further decline of 1.00% to Rs.20.80 on thin volume</p>\n <p><strong>May 27:</strong> Sharp drop of 4.33% to Rs.19.90 despite Sensex gains</p>\n <p><strong>May 29:</strong> Stock stabilises at Rs.19.90; company reports positive financial trend</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.22.99</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div c..." }, { "title": "Are Nexus Surgical and Medicare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-nexus-surgical-and-medicare-ltd-latest-results-good-or-bad-4023716", "imagepath": "", "date": "2026-05-30 19:38:56", "description": "Nexus Surgical's latest financial results for Q4 FY26 present a mixed picture, highlighting both operational improvements and ongoing challenges. The company reported a net profit of ₹0.24 crores, which reflects a significant increase compared to the previous quarter and the same quarter last year, indicating enhanced profitability. This improvement is further underscored by an increase in the profit after tax (PAT) margin to 11.71%, up from 5.80% in the prior quarter, showcasing better cost management and operational efficiency.\n\nHowever, the company's net sales for the quarter declined to ₹2.05 crores, marking a substantial sequential decrease of 30.03% following a remarkable surge of 150.43% in the previous quarter. This volatility in revenue generation raises concerns about the sustainability of the company's growth trajectory. While year-on-year sales showed resilience with a 38.51% increase compared t..." }, { "title": "Nexus Surgical Q4 FY26: Profitability Surge Amid Volatile Revenue Growth", "link": "https://www.marketsmojo.com/news/result-analysis/nexus-surgical-q4-fy26-profitability-surge-amid-volatile-revenue-growth-4022171", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NexusSurgicalan_quaterlyResult_4022171.png", "date": "2026-05-29 17:00:49", "description": "Nexus Surgical and Medicare Ltd., a micro-cap medical essentials trading company, reported its Q4 FY26 results with net profit surging to ₹0.24 crores, marking a 41.18% quarter-on-quarter increase and an impressive 166.67% year-on-year growth. However, the company's revenue trajectory remained erratic, with net sales declining 30.03% sequentially to ₹2.05 crores, despite posting a 38.51% year-on-year gain. Trading at ₹19.90 with an ₹11.00 crore market capitalisation, the stock has delivered a 5.63% return over the past year, marginally underperforming its NBFC sector peers." }, { "title": "Nexus Surgical and Medicare Ltd Reports Positive Financial Trend Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-ltd-reports-positive-financial-trend-amid-market-volatility-4020802", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NexusSurgicalan_fintrenddot_4020802.png", "date": "2026-05-29 16:00:05", "description": "Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has demonstrated a notable turnaround in its recent quarterly performance. The company’s financial trend has shifted from flat to positive, driven by improved revenue growth and margin expansion in the quarter ended March 2026. This development comes amid a challenging market environment and a mixed performance relative to broader indices such as the Sensex." }, { "title": "Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 25", "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-ltd-hits-new-52-week-high-of-rs25-3987489", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NexusSurgicalan_priceRelatedfactors_3987489.png", "date": "2026-05-12 10:35:03", "description": "Surging to a fresh 52-week high of Rs 25 on 12 May 2026, Nexus Surgical and Medicare Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex." }, { "title": "Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 24.51", "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-ltd-hits-new-52-week-high-at-rs2451-3985701", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NexusSurgicalan_priceRelatedfactors_3985701.png", "date": "2026-05-11 13:35:03", "description": "With a 62.97% gain over the past year, Nexus Surgical and Medicare Ltd surged to a fresh 52-week high of Rs 24.51 on 11 May 2026, outpacing the Sensex which declined 3.74% over the same period. This milestone caps a five-day winning streak that has propelled the stock 35.04% higher, underscoring a powerful momentum shift despite a broadly weaker market backdrop." }, { "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3929587", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NexusSurgicalan_mojoScore_3929587.png", "date": "2026-04-02 08:05:02", "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns." }, { "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3917644", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NexusSurgicalan_mojoScore_3917644.png", "date": "2026-03-26 08:03:35", "description": "Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals." }, { "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-on-technical-improvements-3879190", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NexusSurgicalan_mojoScore_3879190.png", "date": "2026-03-09 08:02:54", "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 March 2026, driven primarily by improvements in technical indicators despite persistent valuation and financial trend challenges. The company’s technical outlook has shifted to mildly bullish, prompting a reassessment of its near-term prospects, although fundamental concerns remain." } ], "total": 167, "sid": "105611", "stock_news_url": "https://www.marketsmojo.com/news/nexus-surgical-and-medicare-105611" }, "announcements": [ { "caption": "Results - Financial Results For 31-03-2026", "datetime": "28-May-2026", "details": "Submission of Audited Financial Results for the quarter and year ended 31st March 2026", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 28Th May 2026", "datetime": "28-May-2026", "details": "Submission of Outcome of Board Meeting held on Thursday 28th May 2026", "source": "BSE" }, { "caption": "Announcement Under Reg. 30 - Appointment Of Internal Auditors", "datetime": "28-May-2026", "details": "Appointment of M/s. VMRS & Co. Chartered Accountants as the Internal Auditors of the Company for the F.Y. 2026-27", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 25: Stock plunges 8.61% to Rs.21.01 amid broad market rally

May 26: Further decline of 1.00% to Rs.20.80 on thin volume

May 27: Sharp drop of 4.33% to Rs.19.90 despite Sensex gains

May 29: Stock stabilises at Rs.19.90; company reports positive financial trend

Week Open

Rs.22.99

Week Close

Read full news article

Are Nexus Surgical and Medicare Ltd latest results good or bad?

2026-05-30 19:38:56

Nexus Surgical's latest financial results for Q4 FY26 present a mixed picture, highlighting both operational improvements and ongoing challenges. The company reported a net profit of ₹0.24 crores, which reflects a significant increase compared to the previous quarter and the same quarter last year, indicating enhanced profitability. This improvement is further underscored by an increase in the profit after tax (PAT) margin to 11.71%, up from 5.80% in the prior quarter, showcasing better cost management and operational efficiency. However, the company's net sales for the quarter declined to ₹2.05 crores, marking a substantial sequential decrease of 30.03% following a remarkable surge of 150.43% in the previous quarter. This volatility in revenue generation raises concerns about the sustainability of the company's growth trajectory. While year-on-year sales showed resilience with a 38.51% increase compared t...

Read full news article

Nexus Surgical Q4 FY26: Profitability Surge Amid Volatile Revenue Growth

2026-05-29 17:00:49

Nexus Surgical and Medicare Ltd., a micro-cap medical essentials trading company, reported its Q4 FY26 results with net profit surging to ₹0.24 crores, marking a 41.18% quarter-on-quarter increase and an impressive 166.67% year-on-year growth. However, the company's revenue trajectory remained erratic, with net sales declining 30.03% sequentially to ₹2.05 crores, despite posting a 38.51% year-on-year gain. Trading at ₹19.90 with an ₹11.00 crore market capitalisation, the stock has delivered a 5.63% return over the past year, marginally underperforming its NBFC sector peers.

Read full news article

Nexus Surgical and Medicare Ltd Reports Positive Financial Trend Amid Market Volatility

2026-05-29 16:00:05

Nexus Surgical and Medicare Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has demonstrated a notable turnaround in its recent quarterly performance. The company’s financial trend has shifted from flat to positive, driven by improved revenue growth and margin expansion in the quarter ended March 2026. This development comes amid a challenging market environment and a mixed performance relative to broader indices such as the Sensex.

Read full news article

Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 25

2026-05-12 10:35:03

Surging to a fresh 52-week high of Rs 25 on 12 May 2026, Nexus Surgical and Medicare Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex.

Read full news article

Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 24.51

2026-05-11 13:35:03

With a 62.97% gain over the past year, Nexus Surgical and Medicare Ltd surged to a fresh 52-week high of Rs 24.51 on 11 May 2026, outpacing the Sensex which declined 3.74% over the same period. This milestone caps a five-day winning streak that has propelled the stock 35.04% higher, underscoring a powerful momentum shift despite a broadly weaker market backdrop.

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-04-02 08:05:02

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns.

Read full news article

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-03-26 08:03:35

Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements

2026-03-09 08:02:54

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 March 2026, driven primarily by improvements in technical indicators despite persistent valuation and financial trend challenges. The company’s technical outlook has shifted to mildly bullish, prompting a reassessment of its near-term prospects, although fundamental concerns remain.

Read full news article